Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Not applicable Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20221
20241
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Not yet recruiting3
Recruiting2
Completed1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology & Blood Diseases Hospital, China2
Anhui Provincial Hospital1
Fujian Medical University Union Hospital1
Guangzhou Bio-gene Technology Co., Ltd1
Nanjing Miracle Biotechnology Co., Ltd.1
Peking University People's Hospital1
The First Affiliated Hospital of Soochow University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic8
Lupus Erythematosus, Systemic2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Antiphospholipid Syndrome1
Autoimmune Diseases1
Purpura, Thrombocytopenic1
Scleroderma, Systemic1
Sjogren's Syndrome1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.